Cinical Trials Detail Page - Genesis HealthCare System - Zanesville, Ohio

Oncotype Dx Colon Cancer

The Oncotype DX Colon Cancer Assay for Stage II Colon Carcinoma: Does It Impact on Physican Adjuvant Treatment Decision Making and Patient Satisfaction?

Objective

Eligibility

1) completed resected stage II colon cancer with T3 tumors

2) candidate for adjuvant chemotherapy

Ineligibility

1) Tumors involving the rectum

2) Lymph node positive disease

3) T4 tumors, perforations or obstructions

5) Pts. have contraindications to adjuvant chemotherapy

 

Mayo Clinic Cancer Research Consortium Trial

Physicians must complete pre-study requirements (educational and regulatory.)

Oncotype testing paid per study.

IRB Protocol Number
MCCRC RC0948
Principal Investigator(s)
J. Phillip Kuebler

Clinical Trial Categories

  • Cancer
Sponsor(s)
Columbus Community Clinical Oncology Program
Contact
RN. Annette Barr, RN at 740-588-7816